Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2024-2030

Women's Health Market by Age (13-17 Years, 18-35 Years, 36 Years & Above), Distribution Channel (Hospital, Online, Retail), Application - Global Forecast 2024-2030


The Women's Health Market size was estimated at USD 43.23 billion in 2023 and expected to reach USD 46.99 billion in 2024, at a CAGR 8.97% to reach USD 78.90 billion by 2030.

Global Women's Health MarketThe women's health market includes diagnosis, treatments, medications, surgical procedures, and preventative measures for female-related disorders and diseases. The women's health market focuses on improving disease management and enhancing the general health of the female population. The surging prevalence of hormonal disorders, osteoporosis, anemia, and breast cancer among women have raised the need for adequate diagnosis and appropriate treatment to improve women's health globally. The growing awareness regarding self-healthcare and the availability of women's health products, including multivitamins and protein supplements, is accelerating sales of women's health products and supplements. However, the high cost associated with treating certain female diseases, including breast cancer, may prevent the female population from availing of the treatment. Additionally, the rising research and development (R&D) and the initiatives implemented by governments worldwide to raise awareness regarding early diagnosis of female diseases and to improve women's health are expected to create significant potential to expand the use of women's health products and may propel women to avail for medical treatments to treat the underlying medical conditions.Regional InsightsThe women's health market in the Americas region is highly developed and is attributed to the rising number of female disorders and increasing awareness regarding self-healthcare among women in the region. The governments of the developed and emerging economies, including the U.S., U.K, Australia, Brazil, Canada, India, China, Japan, Germany, and France, among others, are taking initiatives to spread awareness regarding women's diseases and to improve health o the female population across their respective nations. For instance, the Department of Health in Australia launched the National Women's Health Strategy 2020 to 2030 to improve the health and well-being of all women in Australia, especially those at risk of poor health. Asian countries, including South Korea and Japan, are considerably producing various women's health supplements that contain Vitamin E & C, Vitamin B12, marine collagen, protein, and other natural ingredients that can assist women in improving their overall health. Additionally, the rising approval of women's health medications, including those for hormonal disorders and contraceptive pills, and the increasing commercialization of these products are expected to proliferate the use of women's health products.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Women's Health Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Women's Health Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Women's Health Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., Agile Therapeutics, Inc., Alembic Pharmaceuticals Ltd., Amgen Inc., Apothecus Pharmaceutical Corp., Ar-Ex Laboratories Pvt. Ltd., AstraZeneca PLC, AVA Sciences by FemTec Health Inc., Bayer AG, Bharat Serums and Vaccines Ltd., Boston Imaging, Cipla Limited, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., Ferring B.V., GE HealthCare, Gennev, Inc. by Unified Women's Healthcare, Hologic, Inc., Johnson & Johnson Services, Inc., Lupin Limited, Mankind Pharma Ltd., Mira by Quanovate Tech Inc., Mylan N.V. by Viatris, Novartis AG, Pfizer, Inc., Pregna International Ltd., Quest Diagnostics Incorporated, Serum Institute Of India Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens AG, Sysmex Asia Pacific Pte Ltd., Teva Pharmaceutical Industries Ltd., The Himalaya Drug Company, TherapeuticsMD, Inc., Thermo Fisher Scientific Inc., Torrent Pharmaceuticals Ltd., and Triglobal Lifesciences (opc) Pvt. Ltd..

Market Segmentation & Coverage

This research report categorizes the Women's Health Market to forecast the revenues and analyze trends in each of the following sub-markets:

Age
13-17 Years
18-35 Years
36 Years & Above
Distribution Channel
Hospital
Online
Retail
Application
Contraceptives
Endometriosis & Uterine Fibroids
Hormonal Infertility
Menopause
Polycystic Ovary Syndrome
Postmenopausal Osteoporosis
Region
Americas
Argentina
Brazil
Canada
Mexico
United States
California
Florida
Illinois
New York
Ohio
Pennsylvania
Texas
Asia-Pacific
Australia
China
India
Indonesia
Japan
Malaysia
Philippines
Singapore
South Korea
Taiwan
Thailand
Vietnam
Europe, Middle East & Africa
Denmark
Egypt
Finland
France
Germany
Israel
Italy
Netherlands
Nigeria
Norway
Poland
Qatar
Russia
Saudi Arabia
South Africa
Spain
Sweden
Switzerland
Turkey
United Arab Emirates
United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Women's Health Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Women's Health Market?
3. What are the technology trends and regulatory frameworks in the Women's Health Market?
4. What is the market share of the leading vendors in the Women's Health Market?
5. Which modes and strategic moves are suitable for entering the Women's Health Market?

Note: PDF & Excel + Online Access - 1 Year


1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Women's Health Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing cases of hormonal imbalances and chronic diseases in women
5.1.1.2. Rising trend of superfood and increasing availability of multivitamins for women
5.1.1.3. Inclination of women towards natural and plant based health supplements
5.1.2. Restraints
5.1.2.1. High cost of clinical treatments
5.1.3. Opportunities
5.1.3.1. Rising R&D activities for drug development to treat the hormonal disorders
5.1.3.2. Favorable policies initiated by governments worlwide to improve women’s health
5.1.4. Challenges
5.1.4.1. Side-effects associated with consumption of drugs
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework
6. Women's Health Market, by Age
6.1. Introduction
6.2. 13-17 Years
6.3. 18-35 Years
6.4. 36 Years & Above
7. Women's Health Market, by Distribution Channel
7.1. Introduction
7.2. Hospital
7.3. Online
7.4. Retail
8. Women's Health Market, by Application
8.1. Introduction
8.2. Contraceptives
8.3. Endometriosis & Uterine Fibroids
8.4. Hormonal Infertility
8.5. Menopause
8.6. Polycystic Ovary Syndrome
8.7. Postmenopausal Osteoporosis
9. Americas Women's Health Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States
10. Asia-Pacific Women's Health Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam
11. Europe, Middle East & Africa Women's Health Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom
12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player
12.3.1. Merger & Acquisition
12.3.1.1. Bharat Serums and Vaccines will acquire Firstline Pharma, Genomicks to enhance its presence in women’s health segment.
12.3.1.2. Unified Women's Healthcare acquires menopause care platform Gennev.
12.3.1.3. Carlyle and PAI on women’s healthcare.
12.3.1.4. FemTec Health Acquires Nutrimedy, Adds Personalized Nutrition to Women's Health Suite.
12.3.2. Agreement, Collaboration, & Partnership
12.3.2.1. Onsite Women’s Health and Volpara Health Announce National Partnership.
12.3.2.2. HempStreet announces strategic partnership with Gynica.
12.3.3. Investment & Funding
12.3.3.1. Women's health startup Iron Health launches with $4.5M.
12.3.3.2. Kiran Mazumdar Shaw invests in women’s health platform Gytree.com.
12.3.3.3. Organon is going to significantly expand the production of long-acting contraception in the Netherlands.
12.3.4. Award, Recognition, & Expansion
12.3.4.1. Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis.
13. Competitive Portfolio
13.1. Key Company Profiles
13.1.1. Abbott Laboratories
13.1.2. AbbVie Inc.
13.1.3. Agile Therapeutics, Inc.
13.1.4. Alembic Pharmaceuticals Ltd.
13.1.5. Amgen Inc.
13.1.6. Apothecus Pharmaceutical Corp.
13.1.7. Ar-Ex Laboratories Pvt. Ltd.
13.1.8. AstraZeneca PLC
13.1.9. AVA Sciences by FemTec Health Inc.
13.1.10. Bayer AG
13.1.11. Bharat Serums and Vaccines Ltd.
13.1.12. Boston Imaging
13.1.13. Cipla Limited
13.1.14. Eli Lilly and Company
13.1.15. F. Hoffmann-La Roche Ltd.
13.1.16. Ferring B.V.
13.1.17. GE HealthCare
13.1.18. Gennev, Inc. by Unified Women's Healthcare
13.1.19. Hologic, Inc.
13.1.20. Johnson & Johnson Services, Inc.
13.1.21. Lupin Limited
13.1.22. Mankind Pharma Ltd.
13.1.23. Mira by Quanovate Tech Inc.
13.1.24. Mylan N.V. by Viatris
13.1.25. Novartis AG
13.1.26. Pfizer, Inc.
13.1.27. Pregna International Ltd.
13.1.28. Quest Diagnostics Incorporated
13.1.29. Serum Institute Of India Ltd.
13.1.30. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
13.1.31. Siemens AG
13.1.32. Sysmex Asia Pacific Pte Ltd.
13.1.33. Teva Pharmaceutical Industries Ltd.
13.1.34. The Himalaya Drug Company
13.1.35. TherapeuticsMD, Inc.
13.1.36. Thermo Fisher Scientific Inc.
13.1.37. Torrent Pharmaceuticals Ltd.
13.1.38. Triglobal Lifesciences (opc) Pvt. Ltd.
13.2. Key Product Portfolio
14. Appendix
14.1. Discussion Guide
14.2. License & Pricing
FIGURE 1. WOMEN'S HEALTH MARKET RESEARCH PROCESS
FIGURE 2. WOMEN'S HEALTH MARKET SIZE, 2023 VS 2030
FIGURE 3. WOMEN'S HEALTH MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. WOMEN'S HEALTH MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. WOMEN'S HEALTH MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. WOMEN'S HEALTH MARKET DYNAMICS
FIGURE 7. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2030 (%)
FIGURE 8. WOMEN'S HEALTH MARKET SIZE, BY AGE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2030 (%)
FIGURE 10. WOMEN'S HEALTH MARKET SIZE, BY DISTRIBUTION CHANNEL, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
FIGURE 12. WOMEN'S HEALTH MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES WOMEN'S HEALTH MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA WOMEN'S HEALTH MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. WOMEN'S HEALTH MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. WOMEN'S HEALTH MARKET SHARE, BY KEY PLAYER, 2023

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings